Keep it SIMPLE: Improving Anti-Coagulation Medication Adherence
Atrial Fibrillation, Medication Adherence
About this trial
This is an interventional other trial for Atrial Fibrillation focused on measuring anticoagulants, Personal Health Records
Eligibility Criteria
FOCUS GROUPS:
Inclusion Criteria:
Diagnosis of Atrial Fibrillation (Paroxysmal, Persistent, Permanent)
- focus groups 1 & 2: patients diagnosed ≤ 6 months
- focus groups 3 & 4: patients diagnosed ≥ 6 months
Receiving Oral Anticoagulation -Vitamin K Antagonist (VKA) or Novel Oral Anticoagulant (NOAC)- for non-valvular AF
- focus groups 1 & 2: on VKA or NOAC
- focus groups 3 & 4: changed VKA to NOAC within last 6 months
- *Physically and Mentally capable of providing Informed Consent
- *Age 18 years or older
- *Ability to read and understand English
Current Patient of Parkview Physicians Group (PPG)-Cardiology
- 3, 4, and 5 must apply to caregivers, partners, and/or support persons
Exclusion Criteria:
- Absence of History of Atrial Fibrillation (AF)
- *Does not meet Inclusion Criteria
- Anticoagulation with VKA or NOAC for reasons other than non-valvular AF
- *Designated as part of a vulnerable subject population that the investigator or designee identifies to have compromised autonomy related to potential study participation
Currently participating in another Parkview study that involves PHR use
- Only 2 and 4 apply to caregivers, partners, and/or support persons
TECHNOLOGY TRIAL:
Inclusion Criteria:
- Diagnosis of Atrial Fibrillation (Paroxysmal, Persistent, Permanent)
- Receiving Oral Anticoagulation (VKA or NOAC) for non-valvular AF
- Physically and Mentally capable of providing Informed Consent
- Age 18 years or older
- Access to Computer and Internet
- Ability to read and understand English
- Current Patient of PPG-Cardiology
- Willing to have a MyChart account
Exclusion Criteria:
- Absence of History of Atrial Fibrillation (AF)
- Does not meet Inclusion Criteria
- Anticoagulation with VKA or NOAC for reasons other than non-valvular AF
- Unable to physically or cognitively carry out the tasks necessary for utilizing a PHR such as; blindness, loss of function of arms, cognitive impairments (per chart review) that would interfere in learning a new task
- Designated as part of a vulnerable subject population that the investigator or designee identifies to have compromised autonomy related to potential study participation
- Currently participating in another Parkview study that involves PHR use
- Not willing to have a MyChart account
Sites / Locations
- Parkview Research Center; Parkview Health
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Health Messaging (Non-Procedural)
No Health Messaging
PHR messaging of tailored health education pertinent to non-valvular atrial fibrillation and anticoagulant use. Training on the use of MyChart and the AdhereTech smart pill bottle, medication adherence monitored with Surescripts e-prescribing software and AdhereTech smart pill bottle use.
No PHR messaging of tailored health education pertinent to non-valvular atrial fibrillation and anticoagulant use. Standard care, training on the use of MyChart and the AdhereTech smart pill bottle, medication adherence monitored with Surescripts e-prescribing software and AdhereTech smart pill bottle use